Skip to main content

Bausch & Lomb Corp

corporate_fare Company Profile

Bausch & Lomb Corp

BLCO·NYSE·Industrial Applications And Services·CIK 0001860742

Bausch + Lomb Corporation is an integrated eye health business that protects and enhances sight globally. Founded in 1853, the company has approximately 13,000 employees and operates in approximately 100 countries. Bausch + Lomb offers a comprehensive portfolio of approximately 400 products, including contact lenses, intraocular lenses (IOLs), other medical devices, surgical systems and devices, vitamin and mineral supplements, lens care products, prescription eye-medications, and other consumer products. These products enable the company to compete across all areas of the eye health market. Bausch + Lomb is a subsidiary of Bausch Health Companies Inc. (BHC), with BHC directly or indirectly holding 310,449,643 Bausch + Lomb common shares, representing approximately 88% of the issued and outstanding common shares as of February 11, 2026. Bausch + Lomb's common shares began trading on the New York Stock Exchange (NYSE) and the Toronto Stock Exchange (TSX) under the ticker symbol "BLCO" on May 6, 2022, following its initial public offering.

Bausch & Lomb Corp (NYSE:BLCO) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 10 items for BLCO at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-08-12, rated 7/10. Across its 10 most recent items scored 7 or higher, the top rating is 8/10, with 5 rated 8 or above. Recent SEC coverage for BLCO spans 8-K/A, 8-K, 10-Q, DEF 14A.

Recent high-impact activity:

  • Bausch + Lomb Appoints New Chairman and Lead Independent Director
  • At Controlling Shareholder's Request, Bausch + Lomb Overhauls Board and Reaffirms Guidance
  • Bausch + Lomb Q2 Revenue Jumps 9%, Raises Full-Year Guidance; Pharma and Surgical Profits Surge
  • Broad-Based Q2 Growth Drives Bausch + Lomb's 2026 Guidance Raise
  • Bausch + Lomb Reports Strong Q1 2026 Results with Significant Profitability and Cash Flow Improvement

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$5.1B
Net Income
-$360M
Diluted EPS
-$1.02
Op. Cash Flow
$283M
Free Cash Flow
-$66M
Operating Income
$113M
Cash & Equivalents
$383M
Total Debt
$5.05B
Debt / Equity
0.78×
Net Margin
-7.1%
Shares Outstanding
354.21M sh
Source: 10-K · filed 2026-02-18 · accession 0001860742-26-000007

Short Interest & Short Volume

7.75 days to cover

FINRA reported short interest of 3,164,899 shares in BLCO as of the September 15, 2026 settlement, a 7.1% decrease from the prior period — about 7.8 days to cover at its recent average daily volume. On October 2, 2026, 64.3% of BLCO volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)3,164,899 shares as of September 15, 2026
Change vs prior period▼ 7.1%
Days to cover7.75 at avg daily volume of 408,597
Daily short volume (FINRA facilities)64.3% of 189,586 shares on October 2, 2026
5-day average short volume56.2%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with B →
$17.11
52-week range · as of 2026-08-12 $13.53 – $18.91
Market cap
$6.11B
Volume
354.1K (0.9× avg)
3-mo avg 375.9K
Live data · 2026-10-05 02:49 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed BLCO - Latest Insights

BLCO
Aug 12, 2026, 7:01 AM EDT
Filing Type: 8-K/A
Importance Score:
7
Price at Filing: $16.87
Real-time Price: $17.11 info
Change: +$0.240 (+1%) info
Market Cap: $6.111B info
BLCO
Aug 06, 2026, 7:10 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $16.76
Real-time Price: $17.11 info
Change: +$0.350 (+2%) info
Market Cap: $6.111B info
BLCO
Jul 29, 2026, 4:17 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $16.20
Real-time Price: $17.11 info
Change: +$0.910 (+6%) info
Market Cap: $6.111B info
BLCO
Jul 29, 2026, 7:02 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $16.61
Real-time Price: $17.11 info
Change: +$0.500 (+3%) info
Market Cap: $6.111B info
BLCO
Apr 29, 2026, 4:36 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $15.50
Real-time Price: $17.11 info
Change: +$1.61 (+10%) info
Market Cap: $6.111B info
BLCO
Apr 29, 2026, 7:01 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $15.72
Real-time Price: $17.11 info
Change: +$1.39 (+9%) info
Market Cap: $6.111B info
BLCO
Apr 10, 2026, 4:05 PM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $16.49
Real-time Price: $17.11 info
Change: +$0.620 (+4%) info
Market Cap: $6.111B info
BLCO
Feb 18, 2026, 5:19 PM EST
Filing Type: 10-K
Importance Score:
7
Price at Filing: $17.67
Real-time Price: $17.11 info
Change: -$0.560 (-3%) info
Market Cap: $6.111B info
BLCO
Feb 18, 2026, 7:01 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $16.75
Real-time Price: $17.11 info
Change: +$0.360 (+2%) info
Market Cap: $6.111B info
BLCO
Jan 02, 2026, 4:14 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $16.58
Real-time Price: $17.11 info
Change: +$0.530 (+3%) info
Market Cap: $6.111B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets